(Q42915059)

11 November 2017

title

Clinical trial: oral zinc in hepatic encephalopathy (English)

1 reference

11 November 2017

2

K. Nouso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20822500

8 July 2024

author name string

Y. Takuma

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20822500

8 July 2024

Y. Makino

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20822500

8 July 2024

M. Hayashi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20822500

8 July 2024

H. Takahashi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20822500

8 July 2024

language of work or name

English

0 references

publication date

3 September 2010

1 reference

full work available at URL

11 November 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2010.04448.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20822500

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2010.04448.x

8 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2036.2010.04448.x

8 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Alimentary Pharmacology & Therapeutics

8 July 2024

published in

1 reference

11 November 2017

volume

32

1 reference

11 November 2017

issue

9

1 reference

11 November 2017

page(s)

1080-1090

1 reference

Pathogenesis and treatment of portal-systemic encephalopathy: an update

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Minimal hepatic encephalopathy impairs fitness to drive.

8 July 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

8 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

8 July 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis

8 July 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication

8 July 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.

8 July 2024

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Overt hepatic encephalopathy precipitated by zinc deficiency

8 July 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial

8 July 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Correlations between zinc, amino acids and ammonia in liver cirrhosis

8 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Muscle ammonia and glutamine exchange during chronic liver insufficiency in the rat

8 July 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis

8 July 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

8 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

8 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

8 July 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese.

8 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey

8 July 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan

8 July 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Factors associated with poor health-related quality of life of patients with cirrhosis

8 July 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

The MOS 36-ltem Short-Form Health Survey (SF-36)

8 July 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

8 July 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis

8 July 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Ammonia metabolism and hepatic encephalopathy

8 July 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy

8 July 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Rifaximin treatment in hepatic encephalopathy

8 July 2024

32

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis

8 July 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

8 July 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

MELD fails to measure quality of life in liver transplant candidates

8 July 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study

8 July 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Branched-chain amino acids as a protein- and energy-source in liver cirrhosis

8 July 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism

8 July 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Preliminary study of combination therapy with interferon-alpha and zinc in chronic hepatitis C patients with genotype 1b

8 July 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

8 July 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial

8 July 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2010.04448.X

8 July 2024

Identifiers

1 reference

11 November 2017

1 reference